Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.

January 21, 2017 updated by: Tehran University of Medical Sciences

The Study of Outpatient Ketogenic Diet on Seizure Rate, Nutritional Status and Some Biochemical Factors in Children and Adolescent With Refractory Epilepsy.

This study will consider the effectiveness of the ketogenic diet (high-fat, low-carbohydrate, and moderate protein) in treating epilepsy. Investigators enroll a group of eligible epileptic children and adolescent who have been referred from epilepsy center to our clinic and prescribe them ketogenic diet.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

This research will be done to observe efficacy, safety, and tolerability of the classic ketogenic diet (CKD) on an outpatient basis without fasting, caloric and fluid restriction in children with and adolescents with intractable epilepsy.

30 children and adolescents with intractable epilepsy based on inclusion and exclusion criteria have been enrolled in the study, Investigators prescribe them classic ketogenic diet. Efficacy of the diet will be assessed through seizure rates, number of anti-epileptic drug used by the patients, and EEG changes. Seizure frequency will be assessed by seizure record diary that is filled out by family of the patients and will be compared with data that will be taken at 1, 3 months after start of the diet. EEG will be taken at baseline and 3 months after start of the diet. Patients will be reviewed at 1, 3 months after start of the diet at outpatient clinic. Intolerances and Complications will be documented at each clinic visits and via telephone calling during clinic visits intervals to evaluate tolerability and safety of the KD. For close monitoring of the complications along with blood tests and urinalysis Investigators will do echocardiography and renal ultrasound at baseline and 3 months after start of the diet. Laboratory values will be assessed at baseline and 3 months after start of the diet. Also, nutritional status and growth of children will be assessed at baseline and 1, 3 months after start of diet.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tehran, Iran, Islamic Republic of
        • Recruiting
        • Tehran university of medical science, school of nutritional science and dietetics
        • Contact:
        • Principal Investigator:
          • Mona Kavoosi, MSc student

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Ages 1-18 years,
  • The patient has tried at least 3 different AED:s including one combination with two or more different AED:s.
  • The parents are willing to include their child in the study after written and verbal information.
  • Patients with all types of epilepsy can be included.
  • The patient is submitted to our epilepsy center.

Exclusion Criteria:

  • The patient has a medical condition, for example a metabolic disease, where ketogenic diet is contraindicated.
  • The patient's nutritional status is not good enough or intake of fluid is to small to permit treatment with ketogenic diet.
  • No history of hyperlipidemia
  • No history of renal stones
  • No previous treatment with ketogenic diet
  • Beta-oxidation defects - medium-chain acyl dehydrogenase deficiency (MCAD), long-chain acyl dehydrogenase deficiency (LCAD), short-chain acyld dehydrogenase deficiency (SCAD), long-chain 3-hydroxyacyl-coenzyme A (CoA) deficiency, and medium-chain 3- hydroxyacyl-CoA deficiency.
  • The family is expected to have compliance problems with treatment and/or seizure registration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: ketogenic diet
Ketogenic diet
Ketogenic Diet is a high fat, low carbohydrate diet.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
seizure rate
Time Frame: 3 months
The information will be obtained through seizure diary
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: Before and after 1 and 3 months on the classical KD.
Height of the participants will be assessed by stadiometer and Unit for height is cm.
Before and after 1 and 3 months on the classical KD.
Investigating side effects
Time Frame: After 3 months on the classical KD
Side effects will be obtained via parents' reports.
After 3 months on the classical KD
serum Triglyceride
Time Frame: Before and after 3 months on the classical KD
serum Triglyceride will be assessed. Units for serum TG, is mg/dl.
Before and after 3 months on the classical KD
Weight
Time Frame: Before and after 1 and 3 months on the classical KD.
Weight of the participants will be assessed by seca scale and Unit for weight is kilogram.
Before and after 1 and 3 months on the classical KD.
serum Cholesterol,
Time Frame: Before and after 3 months on the classical KD
serum Cholesterol will be assessed. Units for serum Cholesterol is mg/dL.
Before and after 3 months on the classical KD
serum LDL-Cholesterol
Time Frame: Before and after 3 months on the classical KD.
serum LDL-Cholesterol will be assessed. Units for serum LDL-C is mg/dL.
Before and after 3 months on the classical KD.
serum HDL-Cholesterol
Time Frame: Before and after 3 months on the classical KD
serum HDL-Cholesterol will be assessed. Units for serum HDL-C is mg/dL
Before and after 3 months on the classical KD

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Maryam Mahmoudi, MD, PHD, Tehran university of medical science, school of nutritional science and dietetics

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2016

Primary Completion (ANTICIPATED)

February 1, 2017

Study Completion (ANTICIPATED)

March 1, 2017

Study Registration Dates

First Submitted

December 31, 2016

First Submitted That Met QC Criteria

January 21, 2017

First Posted (ESTIMATE)

January 25, 2017

Study Record Updates

Last Update Posted (ESTIMATE)

January 25, 2017

Last Update Submitted That Met QC Criteria

January 21, 2017

Last Verified

September 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractory Epilepsy

Clinical Trials on ketogenic diet

3
Subscribe